MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$16,539,222
Prepaid expenses and
other current assets
$1,451,543
Tax credits
$231,003
Operating lease
right-of-use assets
$300,576
Internal-use software, net
$90,045
Property and equipment,
net
$54,435
Restricted cash
$36,085
Long-term deposits and
other noncurrent...
$35,555
Total current assets
$18,221,768
Total noncurrent
assets
$516,696
Total assets
$18,738,464
Total liabilities and
stockholders' equity
$18,738,464
Total stockholders'
equity
$14,006,977
Total liabilities
$4,731,487
Accumulated deficit
-$101,356,007
Loss of the period
-$5,608,732
Additional paid-in capital
$119,970,514
Total current
liabilities
$3,886,574
Total noncurrent
liabilities
$844,913
Accumulated other
comprehensive income
$996,952
Common stock, 0.0001
par value...
$4,250
Other current
liabilities
$2,153,304
Accounts payable
$1,516,362
Operating lease
liabilities - current
$116,627
Loans - current
$100,281
Defined benefit pension
plan
$389,519
Loans - noncurrent
$273,265
Operating lease
liabilities - noncurrent
$182,129
Back
Back
Balance Sheet
source: myfinsight.com
Gain Therapeutics, Inc. (GANX)
Gain Therapeutics, Inc. (GANX)